Oxycodone Depot (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodone Depot, is an opioid analgesic presented as a depot formulation for oral use. It is intended for the management of moderate to severe chronic pain in adult patients who require continuous, long‑acting opioid therapy.

GNH USA supplies Oxycodone Depot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Depot is an opioid analgesic that acts on the central nervous system to relieve pain. - Chronic cancer pain: provides sustained relief for patients with persistent malignant pain. - Post‑surgical pain: helps manage severe pain following major surgical procedures. - Severe non‑cancer chronic pain: offers long‑acting control for conditions such as severe osteoarthritis or neuropathic pain when other treatments are insufficient.

Adverse reactions to Oxycodone Depot can vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate queasiness. - Drowsiness: increased sedation. - Dry mouth: decreased salivary flow. - Dizziness: light‑headed sensation. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or addiction: potential for misuse. - Seizures: rare convulsive episodes. - Anaphylaxis: life‑threatening allergic reaction. - adrenal insufficiency: rare hormonal imbalance.

When prescribing Oxycodone Depot, clinicians should consider several safety measures. - Assess pain severity and opioid tolerance: ensure the patient requires a long‑acting opioid. - Review medical history: identify respiratory disorders, head injury, or substance‑use disorder. - Monitor for sedation and respiratory function: especially during dose initiation and after dose adjustments. - Avoid concurrent CNS depressants: limit use of alcohol, benzodiazepines, or other sedatives. - Educate patients on proper use and disposal: prevent accidental ingestion. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Oxycodone Depot can interact with several other medicines, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - Central nervous system depressants: concurrent alcohol or barbiturates markedly increase sedation risk. - MAO‑inhibitors: may precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise oxycodone plasma levels. - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce analgesic effect. - Anticholinergic agents: may worsen constipation. - Serotonergic drugs: increase risk of serotonin syndrome. - Diuretics: may intensify orthostatic hypotension.